Growing Integration and Need for Single Point of Contact Drives Healthcare IT Platforms Market

Frost & SullivanIncreasing integration in the European healthcare industry is creating the need for a single point of contact for healthcare IT (HIT) systems, which in turn, is driving the market for HIT platforms. Across Europe, healthcare providers are in search of a single, unified platform for clinical and administrative solutions and healthcare IT vendors with comprehensive product portfolios are attempting to address these needs though individual as well as group solutions.

Frost & Sullivan (http://www.healthcareandlifesciencesIT.frost.com) finds that the European Markets for Healthcare IT Platforms earned revenues of $276.5 million in 2006, and estimates this to reach $526.0 million in 2013.

"Shifting to an integrated platform streamlines workflows, helps reduce costs, improves regulatory compliance, and enhances efficiency, patient and user satisfaction," notes Frost & Sullivan Research Analyst Kiran John. "In addition, it provides ready access to vital information from various access points across the hospital sourced from a managed database."

HIT platforms offer a single, interoperable base on which administrative solutions such as patient administrative systems (PAS) and more advanced clinical solutions such as laboratory information systems (LIMS), accident and emergency care, decision support and radiology information systems (RIS) can function smoothly.

Thus, these platforms not only eliminate the problem of interoperability, but also offer greatly enhanced functionality that can be added as and when the requirement arises. This is perhaps one of the most significant advantages of HIT platforms, as it enables hospitals to realise significant cost savings and improve the care delivery process.

However, the high costs associated with complete overhauls of existing infrastructure are likely to restrain many hospitals from adopting HIT platforms. Cost containment is one of the biggest issues facing the healthcare industry, and although hospitals may be keen on investing in sophisticated new technologies, they may find it difficult to do so within their restricted budgets.

Apart from budget constraints, the varying levels of technological sophistication across Europe pose major implementation challenges to healthcare providers. In addition, numerous other related costs in terms of the time taken for installation and full operation of the systems, training time and workflow interruptions are other areas of concern.

"The industry is still not very receptive to complete HIT overhauls," says Mr. John. "Budgetary restraints, time and change management and the existence of a large number of legacy systems are affecting further penetration of HIT platform adoption across Europe."

Thus, HIT platform providers looking to sell complete solutions need to focus on winning HIS contracts that involve smaller implementations. This will allow them to establish relationships with first-time buyers to whom they can sell greater functionality or more advanced solutions at a later date when more funds are available. For this, they will need to leverage their portfolios and reputation as vendors with a proven track record will be best positioned to create a larger installed base.

Since it is unlikely that care providers will undertake complete replacements for the moment due to the huge expenditure involved, HIT platform vendors would do well to build market share by competing for smaller but valuable contracts. As healthcare becomes progressively more integrated, the existing installations will be able to upgrade with greater ease, and consequently, at lower costs.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the European Markets for Healthcare IT Platforms (M022 - 48), then send an e-mail to Radhika Menon Theodore, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it. with your full name, company name, title, telephone number, fax number, and e-mail address. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Markets for Healthcare IT Platforms, part of the Healthcare and Life Sciences IT Subscription, provides an overview of the market dynamics and revenues, along with a complete analysis of key drivers, restraints, and trends in Germany, France, the United Kingdom, Italy, Spain, Scandinavia and Benelux. In this research service, Frost & Sullivan's expert analysts thoroughly examine the following: clinical information systems and administrative information systems. Interviews with the press are available.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...